about
sameAs
Sensitive periods of substance abuse: Early risk for the transition to dependenceCocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatmentsPerformance on a strategy set shifting task in rats following adult or adolescent cocaine exposure.Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Neural regulation of the time course for cocaine-cue extinction consolidation in rats.Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatmentsWorking memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats.Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.Evolution of autism support and understanding via the World Wide Web.Understanding differences in neurotypical and autism spectrum special interests through Internet forums.mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism.Discovery and development of varenicline for smoking cessation.Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic ratsJuvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behaviorCB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodiesCannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in ratsPerinatal Marijuana Use and the Developing ChildProgress in brain cannabinoid CB2 receptor research: From genes to behaviorGenetic deletion of the dopamine D3 receptor increases vulnerability to heroin in miceNeuropsychopharmacology (NPP): gender balance in journal functionTranslating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disordersNeuropsychopharmacology (NPP): relationships between online attention and citation countsNPP (Neuropsychopharmacology): update on gender balance in journal functionModafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions
P50
Q28075281-5127D839-1095-480F-A029-41707003D43EQ30581979-F516DA02-80C1-442D-B6A9-424B4338CA79Q34473917-C21E1B2C-29DF-4381-B43E-815683C9A649Q36372705-32180DEC-5D30-461C-A65B-3934591F45E8Q36553806-8B68B8DA-A842-4536-931D-14D1442DD55EQ36681100-FDCCD6D2-42A1-457D-B721-5CFB51480130Q38635163-7DAF80F7-123B-4857-A147-148CDCF42CFEQ48527671-C64386AF-2CD1-4917-BA35-1AD48086355DQ50303257-8D2AFEFC-53E5-4C9C-ABD4-E2132F7C7420Q50304821-488BC7F0-E4F2-409E-A585-DA8AB134063DQ51746781-B2F0C426-2FD4-49B1-ABD0-B64ED5D40F14Q52627438-172EC9BE-A00D-45F2-A0EC-9F5B05EB454CQ57040179-5261FE5B-7E93-4F9F-AA08-BB16D2A7A650Q58570522-905CC79C-32BB-4DF3-A3D5-6EFC8A20726DQ61473633-3639252A-E902-4039-9BAF-980D05D446A7Q89394372-0CB31B3F-A529-46DA-BCF1-C9C7358F1619Q90264041-71DAD1D3-0CCC-42B2-8F72-B7691E6DC924Q90903607-5365B171-41D1-431B-A913-5777DA22FC3CQ91107496-E037F5A1-87B0-48A8-BAAC-735EE96122C3Q91314957-D19925BE-D268-4F11-B40B-D6780D920396Q92284092-5C18CF01-0061-4198-8C80-AE5CE6E70772Q92407969-01A6BEF1-2A21-4AFF-85D6-340A2136C293Q93077274-360C0D58-1A04-455C-9C94-9A6F44F3ED4FQ93261576-DD39981F-1093-4259-84F8-6DF2B7ADD2A3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chloe J. Jordan
@ast
Chloe J. Jordan
@en
Chloe J. Jordan
@es
Chloe J. Jordan
@nl
Chloe J. Jordan
@sl
type
label
Chloe J. Jordan
@ast
Chloe J. Jordan
@en
Chloe J. Jordan
@es
Chloe J. Jordan
@nl
Chloe J. Jordan
@sl
prefLabel
Chloe J. Jordan
@ast
Chloe J. Jordan
@en
Chloe J. Jordan
@es
Chloe J. Jordan
@nl
Chloe J. Jordan
@sl
P106
P1153
55433000900
P21
P31
P496
0000-0002-1843-227X